… of therapy, concomitant immunosuppressive therapy, the … infection and reduction in
immunosuppression can cause flares in … usually improve and immunosuppression is reduced [24]. …

… , immunosuppressive regimens designed to abrogate immune-mediated tissue injury from
various autoimmune diseases and graft versus host disease … concomitant use with acyclovir. …

… Five of the patients were receiving concomitant immunosuppressive therapy and three of
these died. Reactivation was not identified in these patients (autopsy did not show T. cruzi …

… , we discuss the immunosuppressive properties of glucocorticoids (GS) and other
immunosuppressive agents commonly used in the treatment of rheumatic diseases. The spectrum of …

… Whether donor or recipient factors, disease duration, concomitant immunosuppression,
simultaneous infections, or presence of bone marrow involvement contribute to the difference of …

… disease, or conditioning and graft versus host disease (GVHD) prophylactic regimens may
eliminate or inhibit host … patients received concomitant immunosuppression including agents …

… Three patients presented with GVHD symptoms approximately 1 week after graft enterectomy
and concomitant cessation of immunosuppression. The suggestive signs included skin …

… N = O synthesis plays a role in the suppression observed in immune function assays during
graft vs host disease (GvHD). By using a parent to F1 model to induce GvHD (C57BL/6J to …

… the underlying disorder and concomitant treatment with immunosuppressive agents. Viral
(… -host disease (GVHD). The exact mechanism by which ATG causes immunosuppression is …

… MiHA plays an essential role in graft-versus-host disease in patients who receive HLA-matched
cells in bone marrow transplantation. MHC class I-related chain A and B (MICA and MICB…